Clinical Trial

Evaluating Factors In Study Experiences of Lymphedema Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 17, 2023 (before its estimated August 2025 completion). Its status may not reflect the trial's current state.
Summary
The study intends to investigate the personal experiences of lymphedema patients who take part in a separate clinical trial including a specific medication intervention. The major focus will be on closely following individuals' rates of trial completion and withdrawal. The data collected from this study will help improve future outcomes for all lymphedema patients as well as those in under-represented demographic groups.
Trial Details
NCT Number NCT05948345
Lead Sponsor Power Life Sciences Inc.
Conditions Lymphedema
Enrollment 500 participants
Start Date 2024-08
Primary Completion 2025-08 (estimated)
Study Completion 2026-08 (estimated)
Updated on ClinicalTrials.gov 2023-07-17